Express.co.uk

Weight-loss jabs 'may be needed for life' unless key changes are made by users

The Sun

Scientists finally discover how long it takes before the weight starts piling back on after stopping fat jabs

Guardian

People who stop weight loss drugs return to original weight within year, analysis finds

Daily Mail

Major study reveals disappointing reality of what happens to the body a year after coming off Ozempic

Metro

I lost half my body weight on Ozempic  this is what happened when I stopped

The Telegraph

Patients who stop taking weight-loss jabs regain lost pounds within months

The Times of India

Weight Loss Tips: Lost it on Wegovy? You might gain it all back in a year

BBC News

Weight loss injections: How do drugs like Wegovy and Mounjaro work?

The BMJ

NICE recommendations on tirzepatide for weight loss could increase NHS access

NHS must accelerate use of weight-loss jabs, say obesity experts

Metaculus

When will the FDA or EMA first approve a drug for the treatment of obesity that causes >25% weight loss?

<h2></h2>

After analyzing data from 11 trials involving over 6,300 patients, a comprehensive Oxford University study has found that people using weight-loss injections typically lost 8kg (18lb) but regained their original weight within 10 months of discontinuing treatment.

After analyzing data from 11 trials involving over 6,300 patients, a comprehensive Oxford University study has found that people using weight-loss injections typically lost 8kg (18lb) but regained their original weight within 10 months of discontinuing treatment.

The study, presented at the European Congress on Obesity in Malaga, found that patients taking newer medications like Wegovy and Mounjaro lost an average of 16kg but regained approximately 10kg within a year of stopping treatment.

The study, presented at the European Congress on Obesity in Malaga, found that patients taking newer medications like Wegovy and Mounjaro lost an average of 16kg but regained approximately 10kg within a year of stopping treatment.

According to the researchers, the rapid weight regain may occur because patients using the drugs don't develop behavioral strategies for maintaining weight loss, as the medications primarily work by suppressing hunger.

According to the researchers, the rapid weight regain may occur because patients using the drugs don't develop behavioral strategies for maintaining weight loss, as the medications primarily work by suppressing hunger.

Study co-author Professor Susan Jebb, an expert in diet and population health at the University of Oxford, said: "These drugs are very effective at helping you lose weight, but when you stop them, weight regain is much faster than [after stopping] diets."

Study co-author Professor Susan Jebb, an expert in diet and population health at the University of Oxford, said: "These drugs are very effective at helping you lose weight, but when you stop them, weight regain is much faster than [after stopping] diets."

The UK's National Institute for Health and Care Excellence (NICE) recommends that patients follow a diet and physical activity program and avoid weight loss injections for more than two years.

The UK's National Institute for Health and Care Excellence (NICE) recommends that patients follow a diet and physical activity program and avoid weight loss injections for more than two years.

Previous research indicates that weight regain after stopping these medications occurs more rapidly than with traditional diets, which typically take at least five years for complete weight return.

Previous research indicates that weight regain after stopping these medications occurs more rapidly than with traditional diets, which typically take at least five years for complete weight return.

Express.co.uk #

The Sun #

Guardian #

Daily Mail #

Metro #

The Telegraph #

The Times of India #

BBC News #

The BMJ #

Metaculus #

Patients taking newer medications like Wegovy and Mounjaro lost an average of 16kg but regained approximately 10kg within a year of stopping treatment, with projections showing complete weight regain within 20 months.</span

Patients taking newer medications like Wegovy and Mounjaro lost an average of 16kg but regained approximately 10kg within a year of stopping treatment, with projections showing complete weight regain within 20 months.

The National Institute for Health and Care Excellence (NICE) currently recommends that patients should not use weight loss injections for longer than two years, creating a potential conflict with the study's findings about weight regain.</span

The National Institute for Health and Care Excellence (NICE) currently recommends that patients should not use weight loss injections for longer than two years, creating a potential conflict with the study's findings about weight regain.

Research indicates that weight regain after stopping these medications occurs more rapidly than with traditional diets, which typically take at least five years for complete weight return.</span

Research indicates that weight regain after stopping these medications occurs more rapidly than with traditional diets, which typically take at least five years for complete weight return.

Scientists speculate that the rapid weight regain may occur because patients using the drugs don't develop behavioral strategies for maintaining weight loss, as the medications primarily work by suppressing hunger.</span

Scientists speculate that the rapid weight regain may occur because patients using the drugs don't develop behavioral strategies for maintaining weight loss, as the medications primarily work by suppressing hunger.

Healthcare experts emphasize that successful long-term weight management requires a comprehensive approach combining medication with lifestyle modifications, behavioral changes, and nutritional support.</span

Healthcare experts emphasize that successful long-term weight management requires a comprehensive approach combining medication with lifestyle modifications, behavioral changes, and nutritional support.

The current approach to weight loss medications is unsustainable and potentially harmful. The high cost of $8,000 per year makes them inaccessible to many, while the rapid weight regain after discontinuation creates a cycle of dependency. Without addressing root causes through lifestyle changes and behavioral support, these drugs merely offer a temporary fix rather than a long-term solution to obesity.

The current approach to weight loss medications is unsustainable and potentially harmful. The high cost of $8,000 per year makes them inaccessible to many, while the rapid weight regain after discontinuation creates a cycle of dependency. Without addressing root causes through lifestyle changes and behavioral support, these drugs merely offer a temporary fix rather than a long-term solution to obesity.

Weight Loss Drug Users Face Full Weight Regain After Stopping

Health

Obesity

United Kingdom

These revolutionary medications represent the most effective pharmaceutical intervention ever developed for obesity treatment, delivering unprecedented weight loss results of 12-18% in clinical trials. The drugs offer a powerful tool for addressing the obesity epidemic, particularly for those who have struggled with traditional weight loss methods, and can transform lives and significantly improve health outcomes.

These revolutionary medications represent the most effective pharmaceutical intervention ever developed for obesity treatment, delivering unprecedented weight loss results of 12-18% in clinical trials. The drugs offer a powerful tool for addressing the obesity epidemic, particularly for those who have struggled with traditional weight loss methods, and can transform lives and significantly improve health outcomes.

The current approach to weight loss medications is unsustainable and potentially harmful. Additionally, the high cost makes them inaccessible to many, while the rapid weight regain after discontinuation creates a cycle of dependency. Without addressing root causes through lifestyle changes and behavioral support, these drugs merely offer a temporary fix rather than a long-term solution to obesity.

The current approach to weight loss medications is unsustainable and potentially harmful. Additionally, the high cost makes them inaccessible to many, while the rapid weight regain after discontinuation creates a cycle of dependency. Without addressing root causes through lifestyle changes and behavioral support, these drugs merely offer a temporary fix rather than a long-term solution to obesity.

Agfundernews

Glp 1 Drugs Are A Tool Not A Panacea Says Tufts Professor Structured Lifestyle Support Including Food Is Medicine Is Critical To Prevent Weight Regai

Healthcentral

Taking Obesity Meds For Lif

There's a 50% chance that the FDA or EMA will first approve a drug for the treatment of obesity that causes >25% weight loss by Dec. 7, 2028, according to the Metaculus prediction community.

There's a 50% chance that the FDA or EMA will first approve a drug for the treatment of obesity that causes &gt;25% weight loss by Dec. 7, 2028, according to the Metaculus prediction community.

Study: People Regain Weight After Stopping Weight-Loss Jabs

WeightStudy: LossPeople DrugRegain UsersWeight FaceAfter FullStopping Weight-Loss Regain After StoppingJabs

The Spin

Metaculus Prediction

Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters